ResQ Pharma is a research & development company that develops drugs and therapies for treating lipophilic drug overdoses and poisonings.
ResQ Pharma has raised $206K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2022.
ResQ Pharma is headquartered in Chicago, United States.
ResQ Pharma is a research & development company that develops drugs and therapies for treating lipophilic drug overdoses and poisonings.
ResQ Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ResQ Pharma — Funding & Investors." VCBacked, June 16, 2022, https://www.vcbacked.co/company/resq-pharma. Accessed August 15, 2026.
VCBacked. (2022). ResQ Pharma — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/resq-pharma
{{cite web |title=ResQ Pharma — Funding & Investors |url=https://www.vcbacked.co/company/resq-pharma |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated